Navigation Links
Letter to Z Trim Shareholders
Date:4/16/2008

ubiquity in the food industry. Over the last several months we have taken bold steps toward achieving that goal, and also toward assuring you, our shareholders, of our absolute commitment to effective corporate governance and regulatory compliance.

We continue to develop and refine our unique technology to create a broad range of diverse products that will deliver value to our customers and thereby our shareholders. We hope you will stay tuned as we bring you future updates about our successes. Thanks again for your continued support.

Sincerely,

Steven Cohen

President and Director

Disclosures About Forward-Looking Statements. This letter contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Report Act of 1995. All statements other than those that are purely historical are forward-looking statements. Words such as "expect," "anticipate," "believe," "estimate," "intend," "plan," "potential" and similar expressions also identify forward-looking statements. Forward-looking statements include statements regarding our prospects for future sales and production efficiencies. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause our actual results, as well as our expectations regarding materiality or significance, to differ materially from those in the forward-looking statements. These factors include the risks that we may not gain significant market acceptance for our products, that our plant currently operates at a loss, and that we face significant competition. For a discussion of a variety of risk factors affecting our business and prospects, see "Risk Factors" in our Annual Report on Form 10-KSB for the year ended December 31, 2007.

Contact: Angela Strickland of Z Trim, +1-847-549-6002


'/>"/>
SOURCE Z Trim
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Breckenridge Pharmaceutical Signs Letter of Intent for Long Term Agreement With Orit Laboratories (West Caldwell, NJ)
2. Open Letter to Presidential Candidates on State Health Care Reform
3. GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting
4. Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
5. MassMutual Offers Free Letter of Intent Template to People with Disabilities and Their Families, Caregivers
6. Isolagen, Inc. Receives Notification Letter from American Stock Exchange
7. Open Letter to Speaker Pelosi on Approval of Mental Health Parity
8. Highlands Acquisition Corp. Receives Non-Compliance Letter From Amex
9. AHCA, Alliance Praise Bipartisan Johnson, Collins Letter Urging Rejection of Bush Medicare Cuts
10. Texas Health Care Association Asks Texas Congressional Delegation to Sign Letter Urging House Budget Committee to Rescind Bush Medicare Cuts
11. Whitemark Homes Signs Letter of Intent to Acquire Metiscan Holdings, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ember 30, 2009A pet owner knows the enormous joy a...in troubled times. Most pets are considered import...ions. A growing body of research now documents the...nt, elderly care, mental illness, physical impairm...rehabilitation of incarcerated youth and adults. ,...
(Date:11/30/2009)...lics tend to drink heavily more often than younger...30 (HealthDay News) -- Older people who are proble... counterparts, a new report finds, possibly becaus...t. , According to a study released this month,... consume more than 40 drinks a week, on average. B...
(Date:11/30/2009)..., Red Cross offers online giving catalog to he...thers ,, WASHINGTON, Nov. 30 /PRNewswire-USNe...icans are entering this holiday season willing to ...nning to dig deep into their own wallets to suppor...ers about donating to charity instead of buying th...
(Date:11/30/2009)...eening, awareness may help delay progression and r...AY, Nov. 30 (HealthDay News) -- Medical care for o...$185.5 billion a year, according to a new study. ,...ile patients pay $36.1 billion in out-of-pocket co...tient and $4,036 per male patient. Women also have...
(Date:11/30/2009)... APR Energy (APR) recently donated me...of La Esperanza during a Free General Health Campa...speranza, Caja Municipal and Huggies. The donation...the communities where they build, own and operate ...was targeted at benefiting the areas surrounding A...
Breaking Medicine News(10 mins):Health News:The therapeutic benefits of the human-animal bond 2Health News:Binge Drinking Not Just a Rite of the Young 2Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 2Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 3Health News:Osteoarthritis Costs U.S. Over $185 Billion a Year 2Health News:APR Energy Donates Medicine and Medical Services to Community of La Esperanza 2
...ic status and non-white race linked to worse outco...-- Minority children and those in poorer neighborh... transplant than white children or those in better...transplant at Children,s Hospital Boston between 1...
...essens worries more than usual care, study finds, ...For older adults, anxiety is an increasingly commo...e behavior therapy may help them ease their worrie...wer depressive symptoms and improved general menta...
... modest, but activity is safe and should be urged,...Day News) -- A regular program of moderate exercis...ably will benefit some of them, a new study has fo...United States, Canada and France. , Some were star...
...and dads snap thousands of photos, recording every...il now, this frenzy of activity could be one more ...ild,s health and developmental progress. , Now Ju... at the same time tracks a child,s developmental m...
...inn. Mayo Clinic researchers have discovered the ...th and development factors that may ultimately al...r cells or stop them from further development. The...that p21-activated kinase 2 (PAK2), a key target f...
...N.Y., April 7 Misonix, Inc. (Nasdaq: MSON ), a ... device technology, which in Europe is used for th... health conditions, announced that it has sold it...ndustrial ultrasonic equipment and recorded approx...
Other Medicine News:Health News:Heart Transplant Failures More Likely in Poor, Minority Kids 2Health News:Cognitive Behavior Therapy Eases Anxiety for Older People 2Health News:Cognitive Behavior Therapy Eases Anxiety for Older People 3Health News:Exercise Might Benefit Some With Heart Failure 2Health News:Exercise Might Benefit Some With Heart Failure 3Health News:Digital album puts focus on kids' health 2Health News:Digital album puts focus on kids' health 3Health News:Mayo researchers discover mechanism of cell type-specific signaling in tumor development 2Health News:Misonix Announces the Sale of Its Ultrasonic Laboratory Business for $3.5 Million to iSonix LLC 2
(Date:11/30/2009)...N.J. and CHICAGO, Nov. 30 Today at...f the Radiological Society of North America (RSN...d the enrollment of the first patient in an intern...fficacy and safety of florbetaben (BAY 94-9172) PE... in the brain, which are a pathological hallmark o...
(Date:11/30/2009)...TEL AVIV, Israel, November 30 Opto...III(TM) dual channel microphone, the most advanced...l magnetic resonance imaging,(fMRI) environments. ... major step forward for fiber,optic microphone tec...r, with,low-latency adaptive noise cancelling. The...
(Date:11/30/2009)... INDIANAPOLIS, Nov. 30 T...roved Cymbalta® (duloxetine HCl) for the main...(GAD) in adults, Eli Lilly and Company (NYSE: LL...ety disorder can be a chronic illness, it is impor...ent option that is effective in both the acute and...
Breaking Medicine Technology:Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 1NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 2NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 3Roxane Laboratories Inc Announces the Launch of Risperidone Oral Solution 1mg mL 53140 1Roxane Laboratories Inc Announces the Launch of Risperidone Oral Solution 1mg mL 53140 2Osteotech Resumes Shipments of Bulgarian Tissue 13259 1Osteotech Resumes Shipments of Bulgarian Tissue 13259 2Osteotech Resumes Shipments of Bulgarian Tissue 13259 3
...Potential of NeoVista,s Epi...9 NeoVista, Inc. made public,yesterday 18-month d...examining its novel epiretinal brachytherapy for t...generation (AMD) at the 41st Scientific Meeting of...tudy, which was initiated,to test the safety and e...
...icals,Inc. (Nasdaq: IDEV ) today announced that i...zation agreement with Teva Pharmaceutical Industri...oclone. Indevus previously,announced promising dat...d,multi-center Phase II trial in patients with per...duced a statistically significant benefit in,multi...
Other Medicine Technology:NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 2NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 3NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 4Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 2Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 3Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 4
...ives. But degenerative or traumatic impairments an...decisive consideration in the developing of the fi...ed joint function that would reproduce the natural...RM Finger System has proven itself in more than 30...
...ives. But degenerative or traumatic impairments an...decisive consideration in the developing of the fi...ed joint function that would reproduce the natural...RM Finger System has proven itself in more than 30...
...drape during total knee surgery. The foot rest is...ing the leg in flexion, and can be rotated. The un...a standard table attachment or it can be sterilize...to the table with the optional sterilizable table ...
Adjustable Leg Support Stand
Medicine Products: